Provided by Tiger Fintech (Singapore) Pte. Ltd.

REMEGEN

84.500
+3.9004.84%
Volume:4.88M
Turnover:410.12M
Market Cap:47.62B
PE:-28.28
High:85.200
Open:82.000
Low:81.650
Close:80.600
52wk High:126.600
52wk Low:11.520
Shares:563.61M
HK Float Shares:208.58M
Volume Ratio:0.99
T/O Rate:2.34%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-2.988
ROE:-40.42%
ROA:-9.72%
PB:18.75
PE(LYR):-28.28
PS:19.53

Loading ...

Does RemeGen’s Narrowed Net Loss and Rising Revenue Shift Sentiment on SEHK:9995’s Recovery Potential?

Simply Wall St.
·
2 hours ago

RemeGen (9995) Announces New Related Transactions Plan and Governance Policy Amendments

Bulletin Express
·
Yesterday

RemeGen Co., Ltd. (9995) Announces 2025 Third Extraordinary General Meeting

Bulletin Express
·
Yesterday

HK Stock Connect Shareholding Changes | November 12

Stock News
·
Nov 12

RemeGen (09995.HK/688331) Announces No Change in Share Capital for October 2025

Bulletin Express
·
Nov 04

JPMorgan Raises REMEGEN (09995) Target Price to HK$77, Upgrades to Neutral

Stock News
·
Nov 04

RemeGen’s Reduced Losses and Telitacicept Results Could Be a Game Changer for RemeGen (SEHK:9995)

Simply Wall St.
·
Nov 04

Bank of Communications International Raises REMEGEN (09995) Target Price to HK$112, Maintains "Buy" Rating

Stock News
·
Nov 04

RemeGen (9995) Announces RMB400 Million Principal-Guaranteed Wealth Management Product Purchase

Bulletin Express
·
Nov 03

REMEGEN (09995) Purchases RMB 400 Million in Wealth Management Products

Stock News
·
Nov 03

RemeGen (SEHK:9995) Valuation in Focus Following Breakthrough Clinical Results and Improved Financials

Simply Wall St.
·
Nov 02

RemeGen (SEHK:9995) Losses Widen 23.9% Annually, Profitability Forecasts Test Investor Optimism

Simply Wall St.
·
Nov 01

RemeGen Posts Q3 Loss Despite Higher Revenue; Shares Rise 7%

MT Newswires Live
·
Oct 31

Stock Track | REMEGEN Soars 8.40% as Hong Kong Biotech Stocks Rally

Stock Track
·
Oct 31

HK Movers|Biotech Shares Soar. 3SBIO up 11%; RemeGen up 8%; SKB BIO up 7%; Junshi Bio up 5%; Hengrui Pharma and Innocare up 4%.

Tiger Newspress
·
Oct 31

RemeGen Co., Ltd.* (9995) Announces 2025 Third Quarter Results

Bulletin Express
·
Oct 30

RemeGen (9995) Announces Renewals of Continuing and One-off Connected Transactions

Bulletin Express
·
Oct 30

Visual Guide to REMEGEN's Q3 2025 Earnings Report

Deep News
·
Oct 30

REMEGEN (09995) Reports Q3 Results: Net Loss Narrows 48.6% YoY to RMB 551 Million

Stock News
·
Oct 30

HK Stock Connect Shareholding Changes as of October 30

Stock News
·
Oct 30